Details of the Drug
General Information of Drug (ID: DM9IPTV)
| Drug Name |
N-Hydroxy-3-phenyl-acrylamide
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Cinnamoylhydroxamic acid; CINNAMOHYDROXAMIC ACID; Hydroxylamine, N-cinnamoyl-; 2-Propenamide, N-hydroxy-3-phenyl-; N-Hydroxycinnamamide; UNII-434STJ4H11; N-Hydroxy-3-phenyl-2-propenamide; NSC 42128; NSC-42128; NSC-44617; NSC 44617; CHEMBL154574; 3669-32-7; 434STJ4H11; WLN: QMV1U1R; N-Hydroxy-3-phenyl-acrylamide; Cinnamohydroxamic acid, (E)-; Cinnamoylhydroxamic acid [INCI]; MAZ 1704; MAZ-1704; 2-Propenamide, N-hydroxy-3-phenyl-, (E)-; 2-Propenamide, N-hydroxy-3-phenyl-, (2E)-; AC1Q5CS7; AC1NS7U4; SCHEMBL559917
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 163.17 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.4 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


